Income Statement Quest PharmaTech Inc.

Stocks

QPT

CA74836M1068

Biotechnology & Medical Research

Delayed Toronto S.E. 09:36:33 2026-09-16 EDT			5-day change	1st Jan Change
0.0250 ^CAD	+25.00%		+25.00%	-28.57%

05-30	Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2026	CI
05-29	Quest PharmaTech Inc. Auditor Raises 'Going Concern' Doubt	CI

9cdea915ede9.S2OUXih6GKGiPsxCqr4QpzJJhoDRshNkFUag3Q7xPnE.CAXLNGMMNdDyCq1w6-1A1QEW0dW7y2cFfyz4sWncVQgTCd9zZiVxmMdnqw

Published financial data: QUEST PHARMATECH INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Revenues	-	-	-	-	-
Total Revenues	-	-	-	-	-
Cost of Goods Sold, Total	-	-	-	-	-
Gross Profit	-	-	-	-	-
Selling General & Admin Expenses, Total	639K	536K	819K	488K	469K
R&D Expenses	152K	299K	496K	329K	242K
Other Operating Expenses, Total	791K	834K	1.32M	817K	711K
Operating Income	-791K	-834K	-1.32M	-817K	-711K
Interest Expense, Total	-13.06K	-21K	-20.68K	-22.64K	-20.33K
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-13.06K	-21K	-20.68K	-22.64K	-20.33K
Income (Loss) On Equity Invest.	-57.75M	-3.1M	-516K	-802K	2.71M
Currency Exchange Gains (Loss)	-1.45K	-724	-354	112	-1.15K
Other Non Operating Income (Expenses)	241K	150K	171K	300K	300K
EBT, Excl. Unusual Items	-58.32M	-3.8M	-1.68M	-1.34M	2.28M
Gain (Loss) On Sale Of Investments	-26.72M	-3.83M	-1.34M	-459K	2.72M
Gain (Loss) On Sale Of Assets	-	300K	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-85.04M	-7.33M	-3.02M	-1.8M	5M
Earnings From Continuing Operations	-85.04M	-7.33M	-3.02M	-1.8M	5M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-85.04M	-7.33M	-3.02M	-1.8M	5M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-85.04M	-7.33M	-3.02M	-1.8M	5M
Net Income to Common Incl Extra Items	-85.04M	-7.33M	-3.02M	-1.8M	5M
Net Income to Common Excl. Extra Items	-85.04M	-7.33M	-3.02M	-1.8M	5M
Per Share Items
Net EPS - Basic	-0.51	-0.04	-0.02	-0.01	0.03
Basic EPS - Continuing Operations	-0.51	-0.04	-0.02	-0.01	0.03
Basic Weighted Average Shares Outstanding	168M	168M	169M	169M	169M
Net EPS - Diluted	-0.51	-0.04	-0.02	-0.01	0.03
Diluted EPS - Continuing Operations	-0.51	-0.04	-0.02	-0.01	0.03
Diluted Weighted Average Shares Outstanding	168M	168M	169M	169M	169M
Normalized Basic EPS	-0.22	-0.01	-0.01	-0	0.01
Normalized Diluted EPS	-0.22	-0.01	-0.01	-0	0.01
Supplemental Items
EBITDA	-789K	-821K	-1.31M	-814K	-
EBITA	-791K	-822K	-1.32M	-817K	-711K
EBIT	-791K	-834K	-1.32M	-817K	-711K
EBITDAR	-762K	-767K	-1.27M	-783K	-
Normalized Net Income	-36.45M	-2.38M	-1.05M	-839K	1.42M
Interest on Long-Term Debt	2.15K	157	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	612K	482K	773K	457K	427K
Research And Development Expense From Footnotes	170K	336K	543K	329K	242K
Net Rental Expense, Total	26.45K	53.71K	46.41K	30.94K	41.94K
Imputed Operating Lease Interest Expense	6.76K	11.92K	7.68K	5.6K	6.82K
Imputed Operating Lease Depreciation	19.7K	41.79K	38.74K	25.33K	35.12K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	270K	153K	472K	84K	80K
Total Stock-Based Compensation	270K	153K	472K	84K	80K

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Assets
Cash And Equivalents	264K	375K	717K	205K	14.36K
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	264K	375K	717K	205K	14.36K
Accounts Receivable, Total	-	-	-	-	-
Other Receivables	320	221K	100K	-	-
Total Receivables	320	221K	100K	-	-
Inventory	-	-	-	-	-
Prepaid Expenses	23.49K	25.53K	18.57K	20.19K	18.52K
Other Current Assets, Total	-	-	-	-	-1
Total Current Assets	288K	622K	836K	225K	32.88K
Gross Property Plant And Equipment	792K	608K	554K	-	-
Accumulated Depreciation	-775K	-605K	-554K	-	-
Net Property Plant And Equipment	16.46K	2.97K	0	-	-
Long-term Investments	90.71M	83.72M	23.63M	22.33M	27.72M
Other Intangibles, Total	-	-	-	-	-
Loans Receivable Long-Term	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	10.42K	10.42K	5.86K	5.86K	5.86K
Total Assets	91.03M	84.36M	24.48M	22.56M	27.75M
Liabilities
Accounts Payable, Total	109K	106K	279K	104K	244K
Accrued Expenses, Total	-	-	44.04K	64.04K	84.38K
Short-term Borrowings	500K	1M	1M	1M	1M
Current Portion of Leases	14K	-	-	-	-
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	623K	1.11M	1.32M	1.17M	1.33M
Long-Term Leases	-	-	-	-	-
Total Liabilities	623K	1.11M	1.32M	1.17M	1.33M
Common Stock, Total	30.62M	30.74M	30.74M	30.74M	30.74M
Additional Paid In Capital	11.06M	11.13M	11.6M	11.69M	11.77M
Retained Earnings	48.78M	41.49M	-19.08M	-20.88M	-15.88M
Comprehensive Income and Other	-50.34K	-114K	-111K	-151K	-199K
Total Common Equity	90.41M	83.25M	23.15M	21.4M	26.43M
Minority Interest	-	-	-	-	-
Total Equity	90.41M	83.25M	23.15M	21.4M	26.43M
Total Liabilities And Equity	91.03M	84.36M	24.48M	22.56M	27.75M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	168M	169M	169M	169M	169M
ECS Total Common Shares Outstanding	168M	169M	169M	169M	169M
Book Value / Share	0.54	0.49	0.14	0.13	0.16
Tangible Book Value	90.41M	83.25M	23.15M	21.4M	26.43M
Tangible Book Value Per Share	0.54	0.49	0.14	0.13	0.16
Total Debt	514K	1M	1M	1M	1M
Net Debt	250K	625K	283K	795K	986K
Debt Equivalent Oper. Leases	212K	430K	371K	247K	336K
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	10.5M	7.33M	6.14M	5.29M	7.96M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	598K	598K	554K	-	-

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Net Income	-85.04M	-7.33M	-3.02M	-1.8M	5M
Depreciation & Amortization - CF	38.56K	1.25K	2.97K	-	-
Amortization of Goodwill and Intangible Assets - (CF)	-	12.24K	-	-	-
Depreciation & Amortization, Total	38.56K	13.49K	2.97K	-	-
(Gain) Loss From Sale Of Asset	57.75M	3.01M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	26.72M	3.83M	1.34M	459K	-2.72M
Asset Writedown & Restructuring Costs	1.95K	-	-	-	-
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	516K	802K	-2.71M
Stock-Based Compensation (CF)	270K	153K	472K	84K	80K
Provision and Write-off of Bad Debts	-	-	100K	-	-
Other Operating Activities, Total	-	-	-	100K	1
Change In Accounts Receivable	32.41K	-221K	21.31K	-	-
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	23.52K	-2.19K	216K	-154K	160K
Change in Other Net Operating Assets	26.12K	-2.04K	11.53K	-1.63K	1.68K
Cash from Operations	-171K	-555K	-342K	-512K	-191K
Capital Expenditure	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-14K	-14K	-	-	-
Cash from Investing	-14K	-14K	-	-	-
Short Term Debt Issued, Total	250K	500K	200K	-	-
Total Debt Issued	250K	500K	200K	-	-
Short Term Debt Repaid, Total	-	-	-200K	-	-
Total Debt Repaid	-	-	-200K	-	-
Issuance of Common Stock	-	89K	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	90K	685K	-	-
Cash from Financing	250K	679K	685K	-	-
Foreign Exchange Rate Adjustments	-	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	65.23K	110K	342K	-512K	-191K
Supplemental Items
Cash Interest Paid	13.06K	2.35K	-	-	-
Levered Free Cash Flow	-111K	-593K	-16.16K	-497K	-215K
Unlevered Free Cash Flow	-103K	-580K	-3.23K	-483K	-203K
Change In Net Working Capital	-82.05K	225K	-345K	56.06K	-162K
Net Debt Issued / Repaid	250K	500K	0	-	-

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Profitability
Return on Assets	-0.37	-0.59	-3.21	-2.17	-1.77
Return on Total Capital	-0.37	-0.6	-3.23	-2.19	-1.78
Return On Equity %	-64.03	-8.44	-12.36	-8.09	20.9
Return on Common Equity	-64.03	-8.44	-12.36	-8.09	20.9
Margin Analysis
Gross Profit Margin %	-	-	-	-	-
SG&A Margin	-	-	-	-	-
EBITDA Margin %	-	-	-	-	-
EBITA Margin %	-	-	-	-	-
EBIT Margin %	-	-	-	-	-
Income From Continuing Operations Margin %	-	-	-	-	-
Net Income Margin %	-	-	-	-	-
Net Avail. For Common Margin %	-	-	-	-	-
Normalized Net Income Margin	-	-	-	-	-
Levered Free Cash Flow Margin	-	-	-	-	-
Unlevered Free Cash Flow Margin	-	-	-	-	-
Asset Turnover
Asset Turnover	-	-	-	-	-
Fixed Assets Turnover	-	-	-	-	-
Receivables Turnover (Average Receivables)	-	-	-	-	-
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	0.46	0.56	0.63	0.19	0.02
Quick Ratio	0.43	0.54	0.62	0.18	0.01
Operating Cash Flow to Current Liabilities	-0.27	-0.5	-0.26	-0.44	-0.14
Days Sales Outstanding (Average Receivables)	-	-	-	-	-
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-	-	-	-	-
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	0.57	1.2	4.32	4.67	3.78
Total Debt / Total Capital	0.57	1.19	4.14	4.47	3.65
LT Debt/Equity	-	-	-	-	-
Long-Term Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	0.68	1.31	5.4	5.18	4.79
EBIT / Interest Expense	-60.52	-39.72	-63.63	-36.09	-34.98
EBITDA / Interest Expense	-57.57	-39.08	-63.48	-35.96	-
(EBITDA - Capex) / Interest Expense	-57.57	-39.08	-63.48	-35.96	-
Total Debt / EBITDA	-0.68	-1.22	-0.76	-1.23	-
Net Debt / EBITDA	-0.33	-0.76	-0.22	-0.98	-
Total Debt / (EBITDA - Capex)	-0.68	-1.22	-0.76	-1.23	-
Net Debt / (EBITDA - Capex)	-0.33	-0.76	-0.22	-0.98	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	-
Gross Profit, 1 Yr. Growth %	-	-	-	-	-
EBITDA, 1 Yr. Growth %	-26.13	4.06	59.96	-37.97	-
EBITA, 1 Yr. Growth %	-26.14	3.97	60.08	-37.89	-12.97
EBIT, 1 Yr. Growth %	-26.14	5.52	57.73	-37.89	-12.97
Earnings From Cont. Operations, 1 Yr. Growth %	-144.74	-91.38	-95.35	-40.32	-377.52
Net Income, 1 Yr. Growth %	-144.74	-91.38	-95.35	-40.32	-377.52
Normalized Net Income, 1 Yr. Growth %	-135.71	-93.48	-51.96	-20.22	-269.85
Diluted EPS Before Extra, 1 Yr. Growth %	-145.46	-91.39	-95.37	-40.32	-377.52
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	-
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-70.09	-81.94	-100	-	-
Total Assets, 1 Yr. Growth %	-48.17	-7.33	-8.68	-7.81	23.01
Tangible Book Value, 1 Yr. Growth %	-48.41	-7.91	-9.9	-7.59	23.51
Common Equity, 1 Yr. Growth %	-48.41	-7.91	-9.9	-7.59	23.51
Cash From Operations, 1 Yr. Growth %	-93.21	224.8	-38.27	49.49	-62.74
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-99.38	433.69	-97.28	2.98K	-56.7
Unlevered Free Cash Flow, 1 Yr. Growth %	-99.43	463.26	-99.44	14.83K	-58.06
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-75.94	-12.33	29.02	-0.39	-
EBITA, 2 Yr. CAGR %	-75.92	-12.37	29.01	-0.29	-26.48
EBIT, 2 Yr. CAGR %	-75.92	-11.72	29.01	-1.02	-26.48
Earnings From Cont. Operations, 2 Yr. CAGR %	153.3	-80.36	-81.16	-83.34	28.69
Net Income, 2 Yr. CAGR %	270.84	-80.36	-81.16	-83.34	28.69
Normalized Net Income, 2 Yr. CAGR %	453.38	-84.74	-83.02	-38.09	16.41
Diluted EPS Before Extra, 2 Yr. CAGR %	270.3	-80.21	-81.21	-83.38	28.69
Net Property, Plant and Equip., 2 Yr. CAGR %	-59.27	-76.76	-	-	-
Total Assets, 2 Yr. CAGR %	352.19	-30.69	-48.15	-8.25	6.49
Tangible Book Value, 2 Yr. CAGR %	142.8	-31.07	-49.39	-8.75	6.83
Common Equity, 2 Yr. CAGR %	142.8	-31.07	-49.39	-8.75	6.83
Cash From Operations, 2 Yr. CAGR %	-83.63	-53.04	41.6	-3.94	-25.37
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-71.93	-81.82	-61.87	-8.47	264.95
Unlevered Free Cash Flow, 2 Yr. CAGR %	-73.06	-82.02	-82.28	-8.77	691.34
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-55.64	-60.8	7.13	1.07	-
EBITA, 3 Yr. CAGR %	-55.62	-60.79	7.12	1.11	-4.71
EBIT, 3 Yr. CAGR %	-55.62	-60.6	7.12	1.11	-5.18
Earnings From Cont. Operations, 3 Yr. CAGR %	114.3	-17.91	-74.87	-72.33	-57.45
Net Income, 3 Yr. CAGR %	168.51	5.84	-74.87	-72.33	-57.45
Normalized Net Income, 3 Yr. CAGR %	204.57	25.92	-78.24	-71.56	-13.33
Diluted EPS Before Extra, 3 Yr. CAGR %	168.64	5.71	-74.78	-72.38	-57.51
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.76	-68.94	-	-	-
Total Assets, 3 Yr. CAGR %	150.23	166.6	-48.15	-37.18	1.17
Tangible Book Value, 3 Yr. CAGR %	106.5	75.75	-49.07	-38.15	0.94
Common Equity, 3 Yr. CAGR %	106.5	75.75	-49.07	-38.15	0.94
Cash From Operations, 3 Yr. CAGR %	-70.87	-55.69	-48.56	44.18	-29.94
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	-69.57	-25.08	-90.35	64.74	-28.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	-70.33	-25.79	-94.35	67.37	-29.59
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-
Gross Profit, 5 Yr. CAGR %	-	-	-	-	-
EBITDA, 5 Yr. CAGR %	-28.77	-35.97	-32.01	-43.08	-
EBITA, 5 Yr. CAGR %	-28.78	-35.97	-31.99	-43.04	-7.85
EBIT, 5 Yr. CAGR %	-28.79	-35.78	-31.99	-43.04	-7.85
Earnings From Cont. Operations, 5 Yr. CAGR %	80.65	-3.79	-18.97	-32.91	-51.7
Net Income, 5 Yr. CAGR %	103.11	7.59	-7.23	-21.86	-51.7
Normalized Net Income, 5 Yr. CAGR %	105.16	11.54	-4.01	-6.76	-57.44
Diluted EPS Before Extra, 5 Yr. CAGR %	98.61	7.34	-7.3	-21.99	-51.59
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-9.28	-34.96	-	-	-
Total Assets, 5 Yr. CAGR %	51.61	45.84	33.33	38.35	-30.86
Tangible Book Value, 5 Yr. CAGR %	82.47	62.35	17.66	6.89	-31.5
Common Equity, 5 Yr. CAGR %	82.48	62.35	17.66	6.89	-31.5
Cash From Operations, 5 Yr. CAGR %	-48.27	-40.32	-45.17	-39.62	-40.3
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-62.76	-35.24	-66.7	-18.83	-58.72
Unlevered Free Cash Flow, 5 Yr. CAGR %	-63.33	-35.54	-75.86	-19.4	-59.22